Science Corporation's Vision-Restoring Chip Receives EU Approval
Science Corporation has received approval from Europe’s medical device regulator for its PRIMA chip designed to restore vision in age-related macular degeneration. The company also noted the FDA granted a designation that could expedite regulatory review, potentially allowing treatment of two rare forms of blindness.
Topics: age-related macular degeneration BCI technology brain-computer interface vision restoration